Multiplikator forward rega marang pendapatan usph.com (USPH)
The stability of U.S. Physical Therapy (USPH) is underpinned by the implementation of ESG standards and the digitalization of its clinics. The forward price-to-sales valuation demonstrates resilience, with the metric holding around 1.80. The operational base relies on a steady patient flow, creating a reliable cash generator. However, labor shortages and stringent regulatory pricing oversight create certain risks for the business's final margins.
USPH (usph.com): rincian analitis lan laporan miturut indikator
- rega saham lan target rega konsensus:
- rincian kapitalisasi pasar:
- rincian valuasi buku bisnis:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas U.S. Physical Therapy|USPH - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas U.S. Physical Therapy, Inc.|USPH - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku USPH|USPH - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan U.S. Physical Therapy|Rasio cepet usph.com
- data bathi bisnis lan rasio investasi:
USPH - Bathi resik|Bathi sing dikarepake U.S. Physical Therapy|USPH - Rasio rega marang bathi|Prakiraan rega marang bathi U.S. Physical Therapy, Inc.|USPH - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan USPH|USPH - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) U.S. Physical Therapy|USPH - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan usph.com|USPH - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep U.S. Physical Therapy
- informasi babagan volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:US Physical Therapy Inc USPH
For U.S. Physical Therapy (USPH), the ratio of market value to projected revenue reflects the network's ability to maintain margins amid rising personnel costs. This coefficient compares current market capitalization with expected sales volume, measuring the premium for future growth. The price action on the forward P/S chart allows for an assessment of the business valuation's adequacy relative to insurance payouts. The stability of this indicator confirms the resilience of the shareholder equity.
Analisis perusahaan pesaing
HCA Healthcare - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Tenet Healthcare Corp (THC)|FMS: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SOLV (Solventum Health)|Encompass Health (EHC) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan UHS (Universal Health Services, Inc.)|DVA (DaVita) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan OPCH (Option Care Health Inc)|SGRY - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Premier, Inc. PINC|Rasio kapitalisasi marang dodolan sing dikarepake nationalvision.com (EYE)|Progyny - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Ardent Health ARDT|SEM: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Astrana Corp|MD (Pediatrix Corp) - Multiplikator Forward P/S|Multiplikator Forward P/S pennantgroup.com|Rasio rega marang prakiraan pendapatan Organogenesis (ORGO)|Rasio rega marang prakiraan pendapatan NUTX (Nutex Health Inc)|Auna Health - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SBC|EOLS: Multiplikator forward rega marang pendapatan|chs.net - Rasio rega marang pendapatan sing dikarepake|SKIN: Multiplikator Forward P/S|MediWound - Rega forward marang dodolan|BTMD (Biote Corp) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep The Joint JYNT|Rasio rega marang prakiraan pendapatan DocGo Inc. (DCGO)|PIII (p3hp.org) - Rega forward marang dodolan|Multiplikator Forward P/S GANX (Gain Therapeutics)|Multiplikator Forward P/S EUDA Health Holdings EUDA|BMGL - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CLGN|CUPR (Cuprina Holdings (Cayman) Ltd) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep concordmedical.com (CCM)|Multiplikator forward rega marang pendapatan AMS|Multiplikator Forward P/S MEDIROM Healthcare Group Inc.|Rasio rega marang prakiraan pendapatan Avalon GloboCare (ALBT)|Rasio kapitalisasi marang dodolan sing dikarepake DIH Group|Rasio rega marang prakiraan pendapatan Longevity Health Holdings XAGE|NIVF (newgenivf.com) - Rega mangsa ngarep marang pendapatan|ATI Physical Therapy Corp - Multiplikator Forward P/S|Rega forward marang dodolan CMAX (CareMax Inc.)|KDLY (Kindly MD Corp) - Multiplikator forward rega marang pendapatan|MODV: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences|SSY: Rega forward marang dodolan|Multiplikator Forward P/S BACK
